Number of the records: 1
Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial
- 1.
SYSNO ASEP 0551303 Document Type A - Abstract R&D Document Type The record was not marked in the RIV R&D Document Type Není vybrán druh dokumentu Title Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial Author(s) Cibula, D. (CZ)
Havel, L. (CZ)
Zemanová, M. (CZ)
Pešek, M. (CZ)
Kolek, V. (CZ)
Spíšek, R. (CZ)
Bartůňková, J. (CZ)
Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
Krasnopolskaya, I. (CZ)
Černovská, M. (CZ)Source Title Journal of Clinical Oncology - ISSN 0732-183X
Roč. 36, 15 S (2018), s. 9051Number of pages 1 s. Language eng - English Country GB - United Kingdom UT WOS 000442916003224 DOI 10.1200/JCO.2018.36.15_suppl.9051 Workplace Institute of Computer Science Contact Tereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800 Year of Publishing 2022
Number of the records: 1